Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 30,989 | 25,478 | 15,345 | 1,718 | 0 |
| Cost of Goods | 1,934 | 340 | 1,478 | N/A | N/A |
| Gross Profit | 29,055 | 25,138 | 13,867 | 1,718 | N/A |
| Operating Expenses | 161,474 | 138,266 | 111,276 | 69,655 | 54,422 |
| Operating Income | -131,485 | -112,788 | -96,931 | -67,937 | -54,422 |
| Interest Expense | 16,895 | 10,672 | 2,582 | 0 | 0 |
| Other Income | 5,437 | 107,033 | 737 | 462 | 301 |
| Pre-tax Income | -142,943 | -16,427 | -98,776 | -67,475 | -54,121 |
| Income Tax | -1,538 | 3,389 | N/A | N/A | N/A |
| Net Income Continuous | -141,405 | -19,816 | -98,776 | -67,475 | -54,121 |
| Net Income | $-141,405 | $-19,816 | $-98,776 | $-67,475 | $-54,121 |
| EPS Basic Total Ops | -2.63 | -0.51 | -2.69 | -2.80 | -3.97 |
| EPS Basic Continuous Ops | -2.63 | -0.51 | -2.69 | -2.47 | -3.97 |
| EPS Diluted Total Ops | -2.63 | -0.51 | -2.69 | -2.80 | -3.97 |
| EPS Diluted Continuous Ops | -2.63 | -0.51 | -2.69 | -2.47 | -3.97 |
| EPS Diluted Before Non-Recurring Items | -2.63 | -2.75 | -2.69 | -2.80 | -3.96 |
| EBITDA(a) | $-131,280 | $-111,759 | $-96,132 | $-67,600 | $-54,152 |